HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in Huntington's disease Clinical Advisory Board formed to support progression of HRN001 into first-in-human studies in 2027 Dr Andy Billinton, CSO will present preclinical data at the upcoming CHDI Foundation Huntington's Disease Therapeutics Conference Cambridge, UK, […]

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntington's Disease and Establishes Clinical Advisory Board GlobeNewswire February 16, 2026 HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in Huntington's disease Clinical Advisory Board formed to support progression of HRN001 into first-in-human studies in

Pulsar Helium Reports Additional High-Pressure Gas Zones Encountered at Jetstream #6, Topaz Helium Project, USA GlobeNewswire February 16, 2026 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH

AMD and TCS to bring state-of-the-art 'Helios' rack-scale AI architecture to India GlobeNewswire February 16, 2026 News Highlights: Enterprises across India will gain access to a new 200MW deployment of the AMD “Helios” rack-scale AI architecture, supporting India's AI initiatives and sovereign AI factories. AMD and TCS will help enterprise customers accelerate AI at scale

(Oslo Bors:EQNR),(Oslo Bors:EQNR01), The shares in Equinor ASA (OSE: EQNR; NYSE: EQNR) will as from today be traded on the Oslo Stock Exchange exclusive the third quarter 2025 cash dividend as detailed below. Ex. date: 16 February 2026 Dividend amount: 0.37 Announced currency: USD This information is published in accordance with the requirements of the

Equinor ASA: Ex. dividend third quarter 2025 today – OSE GlobeNewswire February 16, 2026 The shares in Equinor ASA (OSE: EQNR; NYSE: EQNR) will as from today be traded on the Oslo Stock Exchange exclusive the third quarter 2025 cash dividend as detailed below. Ex. date: 16 February 2026 Dividend amount: 0.37 Announced currency: USD

VICTORIA, Seychelles, Feb. 16, 2026 (GLOBE NEWSWIRE) — As the cryptocurrency market enters a new phase of volatile expansion, leading global digital asset trading platform Zoomex today officially announced the launch of its annual flagship initiative — “February Sprint: Growth Season.” Featuring a total prize pool of up to $100,000, the campaign is designed not

Zoomex Launches “February Rapid Sprint” Growth Season: Redefining New Standards for Contract Trading with Asset Sovereignty and Rule Transparency GlobeNewswire February 16, 2026 VICTORIA, Seychelles, Feb. 16, 2026 (GLOBE NEWSWIRE) — As the cryptocurrency market enters a new phase of volatile expansion, leading global digital asset trading platform Zoomex today officially announced the launch of

(Paris:COX), Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 U.S. NDA submission on track for summer 2026 Nicox to receive milestone payment from Kowa upon submission of the NDA NDA submission based on Phase 3 clinical data showing NCX 470 lowered intraocular pressure by up to 10mmHg in

Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 GlobeNewswire February 16, 2026 Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 U.S. NDA submission on track for summer 2026 Nicox to receive milestone payment from Kowa upon submission of the NDA NDA submission based